Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. The MGI PHARMA Sjögren's Syndrome Study Group.
Nelson
J D
JD
Ramsey Clinic & St. Paul Ramsey Medical Center, USA.
Friedlaender
M
M
Yeatts
R P
RP
Yee
R
R
McDermott
M
M
Orlin
S
S
Gallagher
S C
SC
Shrotriya
R C
RC
D000284:Administration, Oral; D004311:Double-Blind Method; D006801:Humans; D007638:Keratoconjunctivitis Sicca / Q000188:drug therapy* / Q000503:physiopathology; D008916:Miotics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010862:Pilocarpine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D012463:Saliva / Q000187:drug effects / Q000378:metabolism; D012859:Sjogren's Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D014987:Xerostomia / Q000188:drug therapy / Q000503:physiopathology
D008916:Miotics; D010862:Pilocarpine